Pavell Jeff's most recent trade in SILO Pharma Inc was a trade of 50,000 Options (right to buy) done . Disclosure was reported to the exchange on May 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| SILO Pharma Inc | Jeff Pavell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2025 | 50,000 | 50,000 | - | - | Options (right to buy) | |
| Hoth Therapeutics Inc | Jeff Pavell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 25,000 | 25,000 | - | - | Options | |
| Hoth Therapeutics Inc | Pavell Jeff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 25,000 | 25,000 | - | - | Options | |
| Hoth Therapeutics Inc | Jeff Pavell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 7,500 | 7,500 | - | - | Options |